Literature DB >> 31207229

Genetic Mutations Underlying Phenotypic Plasticity in Basosquamous Carcinoma.

Audris Chiang1, Caroline Z Tan2, François Kuonen2, Luqman M Hodgkinson2, Felicia Chiang3, Raymond J Cho4, Andrew P South5, Jean Y Tang2, Anne Lynn S Chang2, Kerri E Rieger6, Anthony E Oro2, Kavita Y Sarin7.   

Abstract

Basosquamous carcinoma (BSC) is an aggressive skin neoplasm with the features of both basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). While genetic drivers of BCC and SCC development have been extensively characterized, BSC has not been well studied, and it remains unclear whether these tumors originally derive from BCC or SCC. In addition, it is unknown which molecular pathways mediate the reprogramming of tumor keratinocytes toward basaloid or squamatized phenotypes. We sought to characterize the genomic alterations underlying sporadic BSC to elucidate the derivation of these mixed tumors. We identifed frequent Hedgehog (Hh) pathway mutations in BSCs, implicating Hh deregulation as the primary driving event in BSC. Principal component analysis of BCC and SCC driver genes further demonstrate the genetic similarity between BCC and BSC. In addition, 45% of the BSCs harbor recurrent mutations in the SWI/SNF complex gene, ARID1A, and evolutionary analysis revealed that ARID1A mutations occur after PTCH1 but before SCC driver mutations, indicating that ARID1A mutations may bestow plasticity enabling squamatization. Finally, we demonstrate mitogen-activated protein kinase pathway activation and the loss of Hh signaling associated with the squamatization of BSCs. Overall, these results support the genetic derivation of BSCs from BCCs and highlight potential factors involved in modulating tumor reprogramming between basaloid and squamatized phenotypes.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31207229      PMCID: PMC6839544          DOI: 10.1016/j.jid.2019.03.1163

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  50 in total

1.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data.

Authors:  Aaron McKenna; Matthew Hanna; Eric Banks; Andrey Sivachenko; Kristian Cibulskis; Andrew Kernytsky; Kiran Garimella; David Altshuler; Stacey Gabriel; Mark Daly; Mark A DePristo
Journal:  Genome Res       Date:  2010-07-19       Impact factor: 9.043

2.  Development of squamous cell carcinoma into basal cell carcinoma under treatment with Vismodegib.

Authors:  C Saintes; M Saint-Jean; A Brocard; L Peuvrel; J J Renaut; A Khammari; G Quéreux; B Dréno
Journal:  J Eur Acad Dermatol Venereol       Date:  2014-07-01       Impact factor: 6.166

3.  Proteomics. Tissue-based map of the human proteome.

Authors:  Mathias Uhlén; Linn Fagerberg; Björn M Hallström; Cecilia Lindskog; Per Oksvold; Adil Mardinoglu; Åsa Sivertsson; Caroline Kampf; Evelina Sjöstedt; Anna Asplund; IngMarie Olsson; Karolina Edlund; Emma Lundberg; Sanjay Navani; Cristina Al-Khalili Szigyarto; Jacob Odeberg; Dijana Djureinovic; Jenny Ottosson Takanen; Sophia Hober; Tove Alm; Per-Henrik Edqvist; Holger Berling; Hanna Tegel; Jan Mulder; Johan Rockberg; Peter Nilsson; Jochen M Schwenk; Marica Hamsten; Kalle von Feilitzen; Mattias Forsberg; Lukas Persson; Fredric Johansson; Martin Zwahlen; Gunnar von Heijne; Jens Nielsen; Fredrik Pontén
Journal:  Science       Date:  2015-01-23       Impact factor: 47.728

4.  Smoothened variants explain the majority of drug resistance in basal cell carcinoma.

Authors:  Scott X Atwood; Kavita Y Sarin; Ramon J Whitson; Jiang R Li; Geurim Kim; Melika Rezaee; Mina S Ally; Jinah Kim; Catherine Yao; Anne Lynn S Chang; Anthony E Oro; Jean Y Tang
Journal:  Cancer Cell       Date:  2015-03-09       Impact factor: 31.743

Review 5.  Cutaneous squamous cell carcinoma: Incidence, risk factors, diagnosis, and staging.

Authors:  Syril Keena T Que; Fiona O Zwald; Chrysalyne D Schmults
Journal:  J Am Acad Dermatol       Date:  2018-02       Impact factor: 11.527

6.  Transcription restores DNA repair to heterochromatin, determining regional mutation rates in cancer genomes.

Authors:  Christina L Zheng; Nicholas J Wang; Jongsuk Chung; Homayoun Moslehi; J Zachary Sanborn; Joseph S Hur; Eric A Collisson; Swapna S Vemula; Agne Naujokas; Kami E Chiotti; Jeffrey B Cheng; Hiva Fassihi; Andrew J Blumberg; Celeste V Bailey; Gary M Fudem; Frederick G Mihm; Bari B Cunningham; Isaac M Neuhaus; Wilson Liao; Dennis H Oh; James E Cleaver; Philip E LeBoit; Joseph F Costello; Alan R Lehmann; Joe W Gray; Paul T Spellman; Sarah T Arron; Nam Huh; Elizabeth Purdom; Raymond J Cho
Journal:  Cell Rep       Date:  2014-11-20       Impact factor: 9.423

7.  Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes.

Authors:  Zhi Jiang Zang; Ioana Cutcutache; Song Ling Poon; Shen Li Zhang; John R McPherson; Jiong Tao; Vikneswari Rajasegaran; Hong Lee Heng; Niantao Deng; Anna Gan; Kiat Hon Lim; Choon Kiat Ong; DaChuan Huang; Sze Yung Chin; Iain Beehuat Tan; Cedric Chuan Young Ng; Willie Yu; Yingting Wu; Minghui Lee; Jeanie Wu; Dianne Poh; Wei Keat Wan; Sun Young Rha; Jimmy So; Manuel Salto-Tellez; Khay Guan Yeoh; Wai Keong Wong; Yi-Jun Zhu; P Andrew Futreal; Brendan Pang; Yijun Ruan; Axel M Hillmer; Denis Bertrand; Niranjan Nagarajan; Steve Rozen; Bin Tean Teh; Patrick Tan
Journal:  Nat Genet       Date:  2012-05       Impact factor: 38.330

8.  Two different scenarios of squamous cell carcinoma within advanced Basal cell carcinomas: cases illustrating the importance of serial biopsy during vismodegib usage.

Authors:  Gefei A Zhu; Uma Sundram; Anne Lynn S Chang
Journal:  JAMA Dermatol       Date:  2014-09       Impact factor: 10.282

9.  Quantification and statistical significance analysis of group separation in NMR-based metabonomics studies.

Authors:  Aaron M Goodpaster; Michael A Kennedy
Journal:  Chemometr Intell Lab Syst       Date:  2011-12-15       Impact factor: 3.491

Review 10.  Phenotypic Plasticity and Cell Fate Decisions in Cancer: Insights from Dynamical Systems Theory.

Authors:  Dongya Jia; Mohit Kumar Jolly; Prakash Kulkarni; Herbert Levine
Journal:  Cancers (Basel)       Date:  2017-06-22       Impact factor: 6.639

View more
  3 in total

Review 1.  Non-Melanoma Skin Cancer: A Genetic Update and Future Perspectives.

Authors:  Marianela Zambrano-Román; Jorge R Padilla-Gutiérrez; Yeminia Valle; José F Muñoz-Valle; Emmanuel Valdés-Alvarado
Journal:  Cancers (Basel)       Date:  2022-05-11       Impact factor: 6.575

2.  c-FOS drives reversible basal to squamous cell carcinoma transition.

Authors:  François Kuonen; Nancy Yanzhe Li; Daniel Haensel; Tiffany Patel; Sadhana Gaddam; Laura Yerly; Kerri Rieger; Sumaira Aasi; Anthony E Oro
Journal:  Cell Rep       Date:  2021-10-05       Impact factor: 9.423

3.  Basosquamous Carcinoma: A Commentary.

Authors:  Christina Fotiadou; Zoe Apalla; Elizabeth Lazaridou
Journal:  Cancers (Basel)       Date:  2021-12-06       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.